Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) - August 11, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Lawsuit - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) - August 11, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Scholar Rock Holding Corp (NASDAQ:SRRK) Reports Q2 2025 Wider Loss but Market Shows Optimism Ahead of Key FDA Decision
Via Chartmill
Tickers SRRK
Exposures Product Safety
Agios Retail Buzz Surges On Saudi Thalassemia Nod As Retail Hails ‘Incredible Recovery’ Despite FDA Concerns
Via Stocktwits
Tickers AGIO
Exposures Product Safety
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) Shares Plunge 20.8% After Q2 2025 Earnings Miss and Weak Guidance
Via Chartmill
Topics Earnings
Tickers LNTH
Exposures Financial Product Safety
Novo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff Pressure
Via Stocktwits
Topics Government World Trade
Tickers HIMS LLY NVO PFE
Exposures Political Product Safety Tariff
7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip
Via The Motley Fool
Topics Earnings
Tickers VRTX
Exposures Financial Product Safety
Nuvectis (NVCT) Q2 Loss Widens 43%
Via The Motley Fool
Tickers NVCT
Exposures Product Safety
Amneal (AMRX) Q2 EPS Jumps 56%
Via The Motley Fool
Topics Economy
Tickers AMRX
Exposures Product Safety Supply Chain
US Market Under Pressure: Amazon, Eastman Chemical, and Hims & Hers Among Top Losers
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Tickers AMZN AVGO BRK-A BRK-B EMN GOOGL
Exposures Artificial Intelligence Intellectual Property Interest Rates
Levi & Korsinsky Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Rocket Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi & Korsinsky Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Rocket Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Nutriband Inc. (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone
Via Investor Brand Network
Tickers BMWYY NTRB
Exposures Product Safety
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reports Positive Phase 1 Safety Results for Lucid-MS
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
FDA Sounds Alarm On Nationwide Butter Recall: Upgrades Risk Over Allergen Warning
Via Benzinga
Exposures Product Safety
Merck (MRK) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers MRK
Exposures Financial Product Safety
$750 Million Projected Market; NRx Pharmaceuticals, Inc files Citizens Petition to FDA Seeking Removal of Benzethonium Chloride from Ketamine Products
Via PRLog
Exposures Product Safety
Why Is Replimune Stock Trading Lower On Monday?
Via Benzinga
Tickers BMY REPL
Exposures Product Safety
Ibogaine by David Dardashti Warns of Kratom’s ‘Gateway’ Dangers, Citing Alarming Trend in Patient Addiction Cases
Via AB Newswire
Exposures Product Safety
AbbVie Raises 2025 Outlook After Q2 Beat
Via The Motley Fool
Tickers ABBV
Exposures Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products
Via Investor Brand Network
Topics Intellectual Property
Tickers NRXP
Exposures Intellectual Property Product Safety
Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Contact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc. (RCKT)
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.